Dergiler / Journal of Health Sciences and Medicine / 2026 / Volume: 9 Issue: 4

Clinical characteristics, risk factors, and short-term outcomes of pediatric thrombosis in hospitalized non-malignant patients: a single-center study

Sayfa
—
Yayın Tarihi
2026-07-20
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There were no significant associations found between thrombophilia studies and radiographic outcomes at three months’ follow-up.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: Thrombosis in pediatrics differs from that in adults and is mainly provoked.
📊
Temel Bulgular & Veri:Methods: In this retrospective study, hospitalized non-cancer children (≤18 years old) with thrombosis were studied from October 2024 to July 2025.
💡
Sonuç & Katkı:There were no significant associations found between thrombophilia studies and radiographic outcomes at three months’ follow-up.
🔬Tür:Research Article
📍Kapsam:2024 Verileri
⚙️Değişkenler:Pediatric thrombosis · central venous catheter · provoked thrombosis

Abstract

Aims: Thrombosis in pediatrics differs from that in adults and is mainly provoked. The main triggers include central venous catheterization, critical illness, infection, and immobilization. The factors associated with illness severity and short-term outcome in hospitalized children without cancer remain poorly defined. The aim of this study was to identify such factors and to describe short-term radiological outcomes. Methods: In this retrospective study, hospitalized non-cancer children (≤18 years old) with thrombosis were studied from October 2024 to July 2025. Data on demographics, risk factors, D-dimer levels, thrombophilia testing, treatment modalities, and radiographic responses at 1 and 3 months after diagnosis were collected. Results: Eighty-eight children (median age 2.0 years, IQR 0.0-11.2 years); 58.0% males. All thrombosis episodes occurred in the venous system, and 62.5% were related to the use of catheters. Immobility (48.9%) and sepsis (40.9%) emerged as the predominant risk factors. D-dimer median was 520 ng/ml (IQR 200-1136), with significantly higher levels observed among ICU/palliative care units than in other wards (p<0.001). Factor V Leiden was detected in 26.0% of genetically tested patients, all in the heterozygous state. Among evaluable patients, partial or complete radiological resolution was observed in 97.6% at 3 months. Conclusion: In hospitalized children without malignancy, thrombosis was predominantly provoked and was associated with central venous catheter exposure and underlying systemic illness. Independent association between d-dimers and high acuity of care indicates that d-dimers reflect systemic illness burden. There were no significant associations found between thrombophilia studies and radiographic outcomes at three months’ follow-up.

🔖

Bu Makaleye Atıf Yap

Ertekin, M., Tahta, N., Siviş, Z. Ö., Güneş, B. T., Özcan, E., Gözmen, S. (2026). Clinical characteristics, risk factors, and short-term outcomes of pediatric thrombosis in hospitalized non-malignant patients: a single-center study. Journal of Health Sciences and Medicine, Volume: 9 Issue: 4. https://doi.org/10.32322/jhsm.1954834

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (24)

  1. O’Brien SH, Stanek JR, Witmer CM, Raffini L. The continued rise of venous thromboembolism across US children’s hospitals. Pediatrics. 2022;149(3):e2021054649. doi:10.1542/peds.2021-054649
  2. Witmer C, Raffini L. Treatment of venous thromboembolism in pediatric patients. Blood. 2020;135(5):335-343. doi:10.1182/blood.2019000930
  3. Paterson RS, Chopra V, Brown E, et al. Selection and insertion of vascular access devices in pediatrics: a systematic review. Pediatrics. 2020;145(suppl 3):S243-S268. doi:10.1542/peds.2020-0818H
  4. Fu M, Yuan Q, Yang Q, et al. Risk factors and incidence of central venous access device-related thrombosis in hospitalized children: a systematic review and meta-analysis. Pediatr Res. 2024;96(7):1568-1593. doi:10.1038/s41390-024-03295-7
  5. Jaffray J, Witmer C, O’Brien SH, et al. Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children. Blood. 2020;135(3):220-226. doi:10.1182/blood.2019002542
  6. Sochet AA, Jaffray J, Branchford BR, et al. Hospital-acquired venous thromboembolism and invasive mechanical ventilation: a report from the Children’s Hospital Acquired Thrombosis Consortium. Pediatr Crit Care Med. 2024;25(2):e82-e90. doi:10.1097/PCC.0000000000003387
  7. Lasagni D, Nosadini M, Molinari AC, et al. Systemic catheter-related venous thromboembolism in children: data from the Italian Registry of Pediatric Thrombosis. Front Pediatr. 2022;10:843643. doi:10.3389/fped.2022.843643
  8. Faustino EVS. Central venous catheter-associated deep venous thrombosis in critically ill children. Semin Thromb Hemost. 2018;44(1): 52-56. doi:10.1055/s-0037-1607200
  9. Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Thrombophilia testing: a British Society for Haematology guideline. Br J Haematol. 2022;198(3):443-458. doi:10.1111/bjh.18239
  10. Middeldorp S, Nieuwlaat R, Baumann Kreuziger L, et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv. 2023;7(22):7101-7138. doi:10.1182/bloodadvances.2023010177
  11. Monagle P, Azzam M, Bercovitz R, et al. American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients. Blood Adv. 2025;9(10):2587-2636. doi:10.1182/bloodadvances.2024015297
  12. Wang G, Liu J, Xu R, Liu X. Elevated plasma D-dimer levels are associated with the poor prognosis of critically ill children. Front Pediatr. 2022;10:1001893. doi:10.3389/fped.2022.1001893
  13. Pelland-Marcotte MC, Bouchard V, Bégin E, Bouhêlier È, Santiago R, Monagle P. Biomarkers in pediatric venous thromboembolism: a systematic review of the literature. J Thromb Haemost. 2023;21(7):1831-1848. doi:10.1016/j.jtha.2023.04.020
  14. Strouse JJ, Tamma P, Kickler TS, Takemoto CM. D-dimer for the diagnosis of venous thromboembolism in children. Am J Hematol. 2009;84(1):62-63. doi:10.1002/ajh.21302
  15. Branchford BR, Mourani P, Bajaj L, Manco-Johnson MJ, Wang M, Goldenberg NA. Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation. Haematologica. 2012;97(4):509-515. doi:10.3324/haematol.2011.047175
  16. Jaffray J, Mahajerin A, Branchford B, et al. A new risk assessment model for hospital-acquired venous thromboembolism in critically ill children: a report from the Children’s Hospital-Acquired Thrombosis Consortium. Pediatr Crit Care Med. 2022;23(1):e1-e9. doi:10.1097/PCC. 0000000000002807
  17. Male C, Lensing AWA, Palumbo JS, et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomized, controlled, phase 3 trial. Lancet Haematol. 2020;7(1):e18-e27. doi:10.1016/S2352-3026(19)30219-4
  18. Halton J, Brandão LR, Luciani M, et al. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomized, controlled, open-label, phase 2b/3, noninferiority trial. Lancet Haematol. 2021;8(1):e22-e33. doi:10.1016/S2352-3026(20)30318-1
  19. Ekim M, Ekim H, Yılmaz YK. The prevalence of factor V Leiden, prothrombin G20210A, MTHFR C677T, and MTHFR A1298C mutations in the healthy Turkish population. Hippokratia. 2015;19(4):309-313.
  20. Gavva C, Sarode R, Zia A. A clinical audit of thrombophilia testing in pediatric patients with acute thromboembolic events: impact on management. Blood Adv. 2017;1(25):2386-2391. doi:10.1182/bloodadvances.2017008940
  21. Deloughery TG, Hunt BJ, Barnes GD, et al. A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing. Res Pract Thromb Haemost. 2022;6(4):e12739. doi:10.1002/rth2.12739
  22. Hickey SE, Curry CJ, Toriello HV. ACMG practice guideline: lack of evidence for MTHFR polymorphism testing. Genet Med. 2013;15(2):153-156. doi:10.1038/gim.2012.165
  23. Campos LR, Petroli M, Sztajnbok FR, Da Costa ES, Brandão LR, Land MGP. Risk factors for the development of hospital-acquired pediatric venous thromboembolism: dealing with potentially causal and confounding risk factors using a directed acyclic graph analysis. PLoS One. 2020;15(11):e0242311. doi:10.1371/journal.pone.0242311
  24. Haut ER, Lau BD, Kraus PS, et al. Preventability of hospital-acquired venous thromboembolism. JAMA Surg. 2015;150(9):912-915. doi:10. 1001/jamasurg.2015.1931